Concepedia

Bone loss during gonadotropin releasing hormone agonist treatment and use of nasal calcitonin

Camille Roux, C Pélissier, V. Listrat, S. Kolta, C Simonetta, Michel Guignard, Maxime Dougados, B Amor

Osteoporosis International · 1995 · 30 citations · 26 references

DOI

Concepts

References

26

Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study.

Karsten Overgaard, M.A. Hansen, S. B. Jensen et al. · BMJ · 1992 · 434 citations · Full text

, , +17

1-YEAR CONTROLLED RANDOMISED TRIAL OF PREVENTION OF EARLY POSTMENOPAUSAL BONE LOSS BY INTRANASAL CALCITONIN

Jean‐Yves Reginster, Adelin Albert, MP Lecart et al. · The Lancet · 1987 · 202 citations

, , +8

The Effect of a Gonadotropin-Releasing Hormone Agonist Analog (Nafarelin) on Bone Metabolism

Julia S. Johansen, Bente Juel Riis, Christian Hassager et al. · The Journal of Clinical Endocrinology & Metabolism · 1988 · 193 citations

, , +16

The effects of menopause on longitudinal bone loss from the spine

J. M. Pouillès, Florence Trémollières, C Ribot · Calcified Tissue International · 1993 · 149 citations

, , +12

REVERSIBLE TRABECULAR BONE DENSITY LOSS FOLLOWING INDUCED HYPO‐OESTROGENISM WITH THE GnRH ANALOGUE BUSERELIN IN PREMENOPAUSAL WOMEN

W Matta, Robert W. Shaw, R. Hesp et al. · Clinical Endocrinology · 1988 · 138 citations

, , +17